Baxano Surgical, Inc. Schedules First Quarter 2014 Results Conference Call for Thursday, May 8, 2014
April 25 2014 - 7:30AM
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans
to release first quarter 2014 financial and operating results after
market close on Thursday, May 8, 2014. Ken Reali, President and
Chief Executive Officer and Tim Shannon, Chief Financial Officer,
will host a conference call starting at 4:30 pm ET on the same day.
To listen to the conference call on your telephone, please dial
(877) 312-8823 for domestic callers and (253) 237-1182 for
international callers approximately ten minutes prior to the start
time. The call will be concurrently webcast. To access the live
audio broadcast or archived recording, use the following link at
http://ir.baxanosurgical.com/events.cfm.
About Baxano Surgical, Inc.
Baxano Surgical, Inc. is a medical device company focused on
designing, developing, and marketing minimally invasive products to
treat degenerative conditions of the spine affecting the lumbar
region. Baxano Surgical currently markets the AxiaLIF® family of
products for single and two level lower lumbar fusion, the VEO®
lateral access and interbody fusion system, iO-Flex®, a proprietary
set of flexible instruments used by surgeons during spinal
decompression procedures, iO-Tome® instrument, which rapidly and
precisely removes bone, specifically the facet joints, which is
commonly performed in spinal fusion procedures and Avance™, an MIS
pedicle screw system used in lumbar spinal fusion procedures.
Baxano Surgical was founded in May 2000 and is headquartered in
Raleigh, North Carolina. For more information, visit
www.baxanosurgical.com.
AxiaLIF, VEO, iO-Tome, iO-Flex and iO-Tome are registered
trademarks of Baxano Surgical.
CONTACT: Baxano Surgical, Inc.
Tim Shannon, Chief Financial Officer
919-926-8762
or
Westwicke Partners
Mark Klausner
443-213-0501
baxanosurgical@westwicke.com